Javascript must be enabled to continue!
Predictors of statin adherence in primary care using real-world data
View through CrossRef
Abstract
Purpose
The objective of this study was to identify predictors of statin adherence in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data.
Methods
The Electronic Practice Based Research Network Linked Dataset was used in this study. Statin adherence was calculated using a modified proportion of days covered (PDC) formula. Individuals with PDC ≥ 80% during the two years of observation period were considered as adherent. All analyses were performed with R software. Descriptive and multivariate logistic regression analyses were performed. Sensitivity analysis was performed using the Akaike Information Criterion model selection method.
Results
Overall, 3,432 patients accounting for 57,227 visits met the selection criteria. The mean PDC was 91.6% (±22.2%), and 72.0% of the patients were adherent to statins (PDC ≥ 80%) in the first two years after the date of first prescription. After adjusting for all other variables, statin adherence was positively associated with age (AOR 1.7, 95% CI 1.4 – 2.0), SEIFA index (AOR 1.8, 95% CI 1.2 – 2.6), polypharmacy (AOR 1.8, 95% CI 1.3 – 2.5) and comorbidities (AOR 1.4, 95% CI 1.1 – 1.7), and negatively associated with the number of statin types (AOR 0.6, 95% CI 0.5 – 0.9) and smoking status (AOR 0.7, 95% CI 0.6 – 0.9). The sensitivity analysis showed similar results as the regression model.
Conclusions
Statin adherence is influenced by an aging, multimorbid population, who are exposed to polypharmacy, multiple statin options and socioeconomic diversity.
Key points
Adherence in the first two years after the first date of statin prescription was measured as proportion of days covered (PDC)
The mean PDC was 91.6% (±22.2%)
72.0% of the patients were adherent to statins, with PDC ≥ 80%
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, polypharmacy and comorbidities
Statin adherence was negatively associated with the number of statin types prescribed to the patients and the smoking status of patients
Plain Language Summary
The objective of this study was to identify predictors of statin adherence among patients in the first two years after the date of first prescription using real-world data. The dataset used was the Electronic Practice Based Research Network Linked Dataset. Statin adherence was calculated using proportion of days covered (PDC). A PDC ≥ 80% during the two years of observation period were considered as adherent. Overall, 3,432 patients were eligible for this study, and 72.0% of them were adherent to statins in the first two years after the date of first prescription. Statin adherence was positively associated with age, area-based social advantage and disadvantage index, number of medicines taken by the patient and number of chronic conditions that the patient suffered. Moreover, statin adherence was negatively associated with the number of statin types prescribed to the patients and smoking status of patients.
Title: Predictors of statin adherence in primary care using real-world data
Description:
Abstract
Purpose
The objective of this study was to identify predictors of statin adherence in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data.
Methods
The Electronic Practice Based Research Network Linked Dataset was used in this study.
Statin adherence was calculated using a modified proportion of days covered (PDC) formula.
Individuals with PDC ≥ 80% during the two years of observation period were considered as adherent.
All analyses were performed with R software.
Descriptive and multivariate logistic regression analyses were performed.
Sensitivity analysis was performed using the Akaike Information Criterion model selection method.
Results
Overall, 3,432 patients accounting for 57,227 visits met the selection criteria.
The mean PDC was 91.
6% (±22.
2%), and 72.
0% of the patients were adherent to statins (PDC ≥ 80%) in the first two years after the date of first prescription.
After adjusting for all other variables, statin adherence was positively associated with age (AOR 1.
7, 95% CI 1.
4 – 2.
0), SEIFA index (AOR 1.
8, 95% CI 1.
2 – 2.
6), polypharmacy (AOR 1.
8, 95% CI 1.
3 – 2.
5) and comorbidities (AOR 1.
4, 95% CI 1.
1 – 1.
7), and negatively associated with the number of statin types (AOR 0.
6, 95% CI 0.
5 – 0.
9) and smoking status (AOR 0.
7, 95% CI 0.
6 – 0.
9).
The sensitivity analysis showed similar results as the regression model.
Conclusions
Statin adherence is influenced by an aging, multimorbid population, who are exposed to polypharmacy, multiple statin options and socioeconomic diversity.
Key points
Adherence in the first two years after the first date of statin prescription was measured as proportion of days covered (PDC)
The mean PDC was 91.
6% (±22.
2%)
72.
0% of the patients were adherent to statins, with PDC ≥ 80%
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, polypharmacy and comorbidities
Statin adherence was negatively associated with the number of statin types prescribed to the patients and the smoking status of patients
Plain Language Summary
The objective of this study was to identify predictors of statin adherence among patients in the first two years after the date of first prescription using real-world data.
The dataset used was the Electronic Practice Based Research Network Linked Dataset.
Statin adherence was calculated using proportion of days covered (PDC).
A PDC ≥ 80% during the two years of observation period were considered as adherent.
Overall, 3,432 patients were eligible for this study, and 72.
0% of them were adherent to statins in the first two years after the date of first prescription.
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, number of medicines taken by the patient and number of chronic conditions that the patient suffered.
Moreover, statin adherence was negatively associated with the number of statin types prescribed to the patients and smoking status of patients.
Related Results
Investigation of the Statin Paradox in Different Populations of VICs
Investigation of the Statin Paradox in Different Populations of VICs
AbstractWhile numerous clinical studies have examined the effect of HMG-CoA reductase inhibitors (statin drugs) on calcific aortic valve disease (CAVD), their conflicting results h...
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
ABSTRACT
Aims
This study focused on patients who were prescribed statins as primary prevention of cardiovascular diseases. This...
Does Preoperative Statin Exposure Reduce Prosthetic Joint Infections and Revisions Following Total Joint Arthroplasty?
Does Preoperative Statin Exposure Reduce Prosthetic Joint Infections and Revisions Following Total Joint Arthroplasty?
Introduction: The pleiotropic effects of statins extend beyond managing cardiovascular health and are suggested to modulate Staphylococcus aureus biofilm formation with prosthetic ...
Atheroma Progression in Hyporesponders to Statin Therapy
Atheroma Progression in Hyporesponders to Statin Therapy
Objective—
Lowering low-density lipoprotein cholesterol (LDL-C) with statins has been demonstrated to slow plaque progression. This antiatherosclerotic effect in patien...
The impact of pre-ictal statin use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage
The impact of pre-ictal statin use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage
Abstract
Background
Pleiotropic effects of statins may be beneficial in alleviating cerebral vasospasm (VS) and improving outcome after aneurysmal s...
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study
Abstract
Introduction
Observational studies suggest statin therapy reduces incident sepsis, but few studies have examined the impact...
Assessment of The Risk Factors for Statin-Related Myopathy in the Indian Population
Assessment of The Risk Factors for Statin-Related Myopathy in the Indian Population
Statins are widely used hypolipidemic drugs with limitations due to myopathy. Several comorbid factors act as predisposing factors for statin-related myopathy (SRM) and are rarely ...
Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma
Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma
Abstract
Introduction: Skeletal related events (SRE) in multiple myeloma (MM) patients are associated with significant morbidity and mortality. Studies assessing the...

